Vescular Mitochondrial Dysfunction as a Pathogenesis of Atherosclerosis

血管线粒体功能障碍是动脉粥样硬化的发病机制

基本信息

  • 批准号:
    15590782
  • 负责人:
  • 金额:
    $ 2.24万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2003
  • 资助国家:
    日本
  • 起止时间:
    2003 至 2004
  • 项目状态:
    已结题

项目摘要

Numerous studies have demonstrated that oxidative stress plays a pivotal rote in the pathogenesis of cardiovascular dieseases. Superoxide anion is formed by univalent reduction of molecular oxygen. Although several enzymes are involved in the generation of superoxide anion, including xanthine oxidase, NADH/NADPH oxidase, lipoxygenase and nitric oxide synthase, one of the largest factories of superoxide anion in vivo is the mitochondrion. In patients with mitochondrial diseases, vascular complications, not only stroke but also coronary artery diseases, are commonly observed in young subjects without risk factors for atherosclerosis. Abnormal mitochondria, which have a defect in substrate utilization in the respiratory chain or of oxidation-phosphorylation coupling, leading to leakage of superoxide anions, are accumulated in the endothelium and vascular smooth muscle cells in mitochondrial diseases. Endothelium-dependent vasodilation was lost at basal level, which was restored by antioxi … More dant ascorbic acid in patients with mitochondrial diseases, suggesting that oxidative stress may be involved in premature cardiovascular diseases and antioxidants may become a therapeutic tool in mitochondrial diseases. Coenzyme Q plays an essential role in the mitochondrial electron-transport chain. Ubiquinol(CoQH2), the reduced form of coenzyme Q, is a lipid-soluble antioxidant. Although CoQH2 supplementation has been shown to have cell protective effects in experimental models, it remains unknown whether endogenous CoQH2 plays a role in the development of atherosclerosis. The aim of this study was to investigate a possible link between CoQH2 and subclincal atherosclerosis in a general population. In apparently healthy subjects, coronary risk factors were evaluated. Endothelial function was estimated by flow-mediated vasodilation of the brachial artery and plaque score of the common carotid artery were assessed by ultrasonography. Plasma levels of CoQH2 were determined by ELISA. Unexpectedly, univariate analyses revealed that CoQH2 was significantly and positively correlated with risk factors of metabolic sydrome, body mass index, triglyceride, mean arterial pressure, and insulin resistance estimated by HOMA. There was a significant positive relationship between CoQH2 and MDA-modified LDL, a marker of oxidative stress. CoQH2 was also inversely correlated with flow-mediated vasodilation and positively correlated with plaque score. Multiple regression analysis composing of classical risk factors revealed that CoQH2 was an independent determinant of flow-mediated vasodilation and plaque score, respectively. Thus, ubiquinol was paradoxically associated with endothelial dysfunction and subclinical atherosclerosis in subjects with metabolic syndrome. Our results suggest that ubiquinol may be compensatory elevated to prevent atherosclerosis. Less
大量研究表明,氧化应激在心血管疾病的发病机制中起着关键作用。超氧阴离子是由分子氧的单价还原形成的。虽然有几种酶参与超氧阴离子的生成,包括黄嘌呤氧化酶、NADH/NADPH氧化酶、脂肪加氧酶和一氧化氮合酶,但体内最大的超氧阴离子工厂之一是线粒体。在线粒体疾病患者中,血管并发症,不仅是中风,还有冠状动脉疾病,通常在没有动脉粥样硬化危险因素的年轻受试者中观察到。线粒体疾病时,内皮细胞和血管平滑肌细胞内积聚了异常线粒体,这些线粒体在呼吸链中利用底物或氧化-磷酸化偶联中存在缺陷,导致超氧阴离子泄漏。在线粒体疾病患者中,抗坏血酸含量较高,提示氧化应激可能与早期心血管疾病有关,抗氧化剂可能成为线粒体疾病的治疗工具。辅酶Q在线粒体电子传递链中起重要作用。泛醇(CoQH2)是辅酶Q的还原形式,是一种脂溶性抗氧化剂。尽管CoQH2补充在实验模型中已被证明具有细胞保护作用,但内源性CoQH2是否在动脉粥样硬化的发展中发挥作用仍不清楚。本研究的目的是研究CoQH2与普通人群亚临床动脉粥样硬化之间的可能联系。在表面健康的受试者中,评估冠状动脉危险因素。通过血流介导的肱动脉血管舒张评估内皮功能,超声评估颈总动脉斑块评分。ELISA法检测血浆CoQH2水平。出乎意料的是,单因素分析显示,CoQH2与HOMA估计的代谢综合征、体重指数、甘油三酯、平均动脉压和胰岛素抵抗的危险因素显著正相关。CoQH2与mda修饰的低密度脂蛋白(一种氧化应激标志物)之间存在显著正相关。CoQH2与血流介导的血管舒张呈负相关,与斑块评分呈正相关。由经典危险因素组成的多元回归分析显示,CoQH2分别是血流介导的血管舒张和斑块评分的独立决定因素。因此,泛醇与代谢综合征患者的内皮功能障碍和亚临床动脉粥样硬化有矛盾的关系。我们的研究结果表明,泛醇可能通过补偿性升高来预防动脉粥样硬化。少

项目成果

期刊论文数量(34)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
動脈硬化と血管内皮機能
动脉硬化与血管内皮功能
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    松岡秀洋
  • 通讯作者:
    松岡秀洋
Regulation of cytokine-induced nitric oxide synthesis by asymmetric dimethylarginine : Role of dimethylarqinine dimethylaminohydrolase.
不对称二甲基精氨酸调节细胞因子诱导的一氧化氮合成:二甲基精氨酸二甲氨基水解酶的作用。
  • DOI:
  • 发表时间:
    2003
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Ueda S;Matsuoka H et al.
  • 通讯作者:
    Matsuoka H et al.
血管内皮障害と治療効果-高血圧
血管内皮疾病及其治疗效果——高血压
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kumagai K;Nakashima H;Saku K.;Kawada T et al.;松岡秀洋
  • 通讯作者:
    松岡秀洋
高脂血圧ナビゲーター
高脂血症导航仪
  • DOI:
  • 发表时间:
    2003
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Seiji Ueda;Seiya Kato;Hidehiro Matsuoka;Masumi Kimoto;Seiya Okuda;Minoru Morimatsu;Tsutomu Imaizumi;松岡秀洋(分担執筆);松岡秀洋 他
  • 通讯作者:
    松岡秀洋 他
血管の老化のメカニズム
血管老化的机制
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Taguchi A;Matsuyama T;Moriwaki H;Hayashi T;Hayashida K;Nagatsuka K;Todo K;Mori K;Stern D;Soma T;Naritomi N;Kawada T et al.;松岡秀洋
  • 通讯作者:
    松岡秀洋
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MATSUOKA Hidehiro其他文献

MATSUOKA Hidehiro的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MATSUOKA Hidehiro', 18)}}的其他基金

Vascular Protective Effects of PPAR Ligands ; Anti-Polymorphonuclear Leukocyte Activity
PPAR 配体的血管保护作用;
  • 批准号:
    18590825
  • 财政年份:
    2006
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Circulating Polymorphonuclear Leukocytes Cell as a Risk Factor for Endothelial injury in Humans
循环多形核白细胞是人类内皮损伤的危险因素
  • 批准号:
    13670770
  • 财政年份:
    2001
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Tetrahydrobiopterin ; Vasculoprotective Mechanisms and Its Therapeutic Application
四氢生物蝶呤;
  • 批准号:
    11670723
  • 财政年份:
    1999
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似国自然基金

上皮钠离子通道(ENaC)在血管内皮的功能和作用
  • 批准号:
    81170236
  • 批准年份:
    2011
  • 资助金额:
    60.0 万元
  • 项目类别:
    面上项目
体外构建角膜内皮细胞膜片行后弹力层内皮移植后的功能评价
  • 批准号:
    31140025
  • 批准年份:
    2011
  • 资助金额:
    10.0 万元
  • 项目类别:
    专项基金项目

相似海外基金

Enhancing parasympathetic activity to reduce vascular oxidative stress and endothelial dysfunction
增强副交感神经活性,减少血管氧化应激和内皮功能障碍
  • 批准号:
    10185061
  • 财政年份:
    2021
  • 资助金额:
    $ 2.24万
  • 项目类别:
Enhancing parasympathetic activity to reduce vascular oxidative stress and endothelial dysfunction
增强副交感神经活性,减少血管氧化应激和内皮功能障碍
  • 批准号:
    10418658
  • 财政年份:
    2021
  • 资助金额:
    $ 2.24万
  • 项目类别:
Enhancing parasympathetic activity to reduce vascular oxidative stress and endothelial dysfunction
增强副交感神经活性,减少血管氧化应激和内皮功能障碍
  • 批准号:
    10625349
  • 财政年份:
    2021
  • 资助金额:
    $ 2.24万
  • 项目类别:
Chronic Hookah (Waterpipe) Smoking, Vascular Dysfunction, Inflammation and Oxidative Stress
慢性吸水烟、血管功能障碍、炎症和氧化应激
  • 批准号:
    10475100
  • 财政年份:
    2020
  • 资助金额:
    $ 2.24万
  • 项目类别:
Mitochondrial oxidative stress: a target for treatment of doxorubicin-associated vascular endothelial dysfunction
线粒体氧化应激:治疗阿霉素相关血管内皮功能障碍的靶点
  • 批准号:
    9909393
  • 财政年份:
    2020
  • 资助金额:
    $ 2.24万
  • 项目类别:
Chronic Hookah (Waterpipe) Smoking, Vascular Dysfunction, Inflammation and Oxidative Stress
慢性吸水烟、血管功能障碍、炎症和氧化应激
  • 批准号:
    10263274
  • 财政年份:
    2020
  • 资助金额:
    $ 2.24万
  • 项目类别:
Mitochondrial oxidative stress: a target for treatment of doxorubicin-associated vascular endothelial dysfunction
线粒体氧化应激:治疗阿霉素相关血管内皮功能障碍的靶点
  • 批准号:
    10403420
  • 财政年份:
    2020
  • 资助金额:
    $ 2.24万
  • 项目类别:
Regulation of oxidative stress and vascular remodeling by EBP50
EBP50 对氧化应激和血管重塑的调节
  • 批准号:
    9920603
  • 财政年份:
    2017
  • 资助金额:
    $ 2.24万
  • 项目类别:
Regulation of vascular endothelial cell bioenergetics by H2S in health and under oxidative stress
健康和氧化应激下 H2S 对血管内皮细胞生物能的调节
  • 批准号:
    278990
  • 财政年份:
    2013
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Fellowship Programs
Endothelial Dysfunction, Oxidative Stress and Risk of Peripheral Arterial Disease
内皮功能障碍、氧化应激和外周动脉疾病的风险
  • 批准号:
    7923971
  • 财政年份:
    2009
  • 资助金额:
    $ 2.24万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了